Last updated: May 18, 2016
|CMS Measure ID:||CMS161v3|
Percentage of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified
|Initial Patient Population:||
All patients aged 18 years and older with a diagnosis of major depressive disorder (MDD)
Equals Initial Patient Population
Patients with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified
|Measure Steward:||American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)|
|National Quality Strategy Domain:||Effective Clinical Care|
|Next Version:||Adult Major Depressive Disorder (MDD): Suicide Risk Assessment|
Higher score indicates better quality
It is expected that a suicide risk assessment will be completed at the visit during which a new diagnosis is made or at the visit during which a recurrent episode is first identified (ie, at the initial evaluation). This measure is an episode-of-care measure and should be reported for each instance of a new or recurrent episode of MDD; every new or recurrent episode will count separately in the Initial Patient Population.
Use of a standardized tool or instrument to assess suicide risk will meet numerator performance. Standardized tools can be mapped to the concept Intervention, Performed: Suicide Risk Assessment included in the numerator logic below.
The measure description outlined in the header for this measure states, ‘patients aged 18 years and older’ while the logic statement states, ‘>= 17 year(s) starts before start of Measurement Period’. The logic statement, as written, captures patients who turn 18 years old during the measurement period so that these patients are included in the measure. To ensure all patients with major depressive disorder (MDD) are assessed for suicide risk, there are two clinical quality measures addressing suicide risk assessment; CMS 177 covers children and adolescents aged 6 through 17, and CMS 161 covers the adult population aged 18 years and older.